NCT01539837View on ClinicalTrials.gov

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Parkinson's Disease
Interventions
DRUG

Deferiprone 20mg

20mg/kg/d Deferiprone divided into two equal doses (morning and evening), every day for 6 months

DRUG

Placebo

Feriprox placebo administered orally at the same dosing volume as the 20mg/kg/day feriprox per day

DRUG

Deferiprone 30mg

30mg/kg/d Deferiprone divided into two equal doses (morning and evening), every day for 6 months

Trial Locations (1)

W120NN

Centre for Neuroscience, Imperial College London, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT01539837 - A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease | Biotech Hunter | Biotech Hunter